Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022–2023Duygu İşlek, Vani Vannappagari, Stefan Baral et al.|PLoS ONE|2025Cited by 3